A doctor-supervised medical weight management programme using tirzepatide — commonly known by the brand Mounjaro®. Eligibility is assessed by your doctor based on your medical history, BMI, and overall health profile.
Tirzepatide is a once-weekly injectable medication that works by activating two hormones — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) — that regulate appetite, blood sugar, and energy metabolism. Clinical trials have demonstrated average weight loss of 15–22% of body weight over 72 weeks.
At IVI Medical Clinic, The medication is prescribed as part of a comprehensive, doctor-supervised weight management programme that includes regular follow-up, lifestyle guidance, and blood monitoring.
Treatment begins with a thorough medical assessment including blood tests and health history review. Dosing starts low and is gradually titrated to the optimal therapeutic dose. We monitor you every 4–8 weeks and adjust the programme as needed for suitable results and minimal side effects.
Book a medical weight management consultation at IVI Medical Clinic.
